Recent Accomplishments and Development Prospects

A Rapidly Growing Centre!

In 2006, the CRHMR undertook a significant strategic redirection project that will continue for the next few years with the support of the Maisonneuve-Rosemont Hospital and its foundation.

The objective: to become a leader in its four research areas by creating a culture that is centered on performance, innovation and partnerships.

A Leading Scientific Program
A Recruitment Policy Based on Excellence
Developing Partnerships
Expansion of Facilities

A leading Scientific Program

Following the nomination of Dr Denis Claude Roy as the new research director in April of 2006, the CRHMR realigned its scientific program of its 4 research axes.
The following recent achievements are a testament to the relevance of the choices made.

  • A grant of $5.8 million was obtained from the Minister of Economic Development, Innovation and Export Trade of Quebec to create the Centre of Excellence for Cellular Therapy (CETC).
  • A grant of $3.25 million was obtained from the Canada Foundation for Innovation in partnership with the IRIC to accelerate the commercialization of new cancer treatments.
  • A grant of $3.8 million was obtained from the Canada Foundation for Innovation to purchase equipment for the CETC.
  • Three grants for a total of close to $2 million were obtained from the Canada Foundation for Innovation’s Leaders Opportunity Fund, which were allocated to Dr Isabelle Brunette, Dr Leonard Levin and Dr Dindial Ramotar.
  • Research chairs in the amount of $2 million from the Wolfe Foundation and $1 million from the Antoine Turmel Foundation were obtained for macular degeneration.
  • A donation of $2 million was received from the Antoine Turmel Foundation to develop the Vision Health Research Axis.
  • Research Chair in biophotonics was given to Dr Isabelle Brunette; the Charles-Albert Poissant Research Chair of $500 000 funded by a group of private donors;
  • A private donation of $1 million was obtained to further research in the area of nephrology.
  • Outstanding performance in the two recent fellowship competitions of the FRSQ. The CRHMR also ranked first at the University of Montreal.

These combined achievements will allow the CRHMR teams to continue conducting quality research work over the next few years.

Top

A Recruitment Policy Based on Excellence

With the goal to consolidate and develop its research teams, the CRHMR has established a targeted recruitment policy that is coherent with its scientific program and that meets its standards for high performance.

Recent recruitment of 9 research investigators: Dr Gina Mollica, Dr Janetta Bijl, Dr Sylvie Lesage, Dr El Bachir Affar and Dr Martin Guimond in immunology-oncology; Dr Ellen Freeman, Dr Leonard Levin and Dr Santiago Costantino in vision health; and Dr Stéphane Lefrançois in nephrology.

Recruitment to follow: 3 research investigators in immunology-oncology, 1 research investigator in nephrology, 6 research investigators in vision health, and 1 research investigator in clinical research.

This policy will also serve to attract quality students in order to prepare the next generation of leading research investigators

If you wish to join our team, please visit our section on Careers and Internships.


Developing Partnerships

A number of partnerships have been recently established or are currently under way. These will allow research investigators to maximize their research findings:

Expansion of Facilities

Increasing the current number of research teams and creating the Centre of Excellence for Cellular Therapy have led the CRHMR to undertake a rather significant facility expansion project.
This year, the CRHMR will obtain additional rooms to meet its recruitment objectives. In addition to this, the Centre’s management team is working in close collaboration with key partners on completing a major real estate expansion project by 2012.

Top